Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Palladium Network Palladium Network +6.43%
#3 Cryptopia Cryptopia +4.36%
#4 SIXSEVEN SIXSEVEN +4.11%
#5 Kinetiq Kinetiq +3.41%
#6 Test Test +3.32%
#7 Movement Movement +3.31%
#8 Victoria VR Victoria VR +3.17%
#9 Jito Jito +3.05%
#10 COTI COTI +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBR
Rankning i aktier #42059
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b clinical trials. It is designed to address moderate to severe forms of Congenital Ichthyosis (CI), a group of uncommon genetic disorders affecting skin keratinization. TMB-002, a proprietary topical rapamycin, currently undergoing Phase 2b clinical trials. This therapy targets facial angiofibroma associated with Tuberous Sclerosis Complex, a complex genetic disorder characterized by the growth of benign tumors in multiple organs. TMB-003, a unique Sitaxsentan formulation functioning as a selective endothelin-A receptor antagonist, which is in preclinical development for various sclerotic skin diseases. Additionally, through a licensing agreement with AFT Pharmaceuticals Limited, Timber Pharmaceuticals is advancing two topical minocycline therapies: BPX-01, now in Phase 3 development for treating inflammatory lesions of acne vulgaris. BPX-04, which is prepared for Phase 3 trials, targeting papulopustular rosacea. Founded in 2019, Timber Pharmaceuticals is headquartered in Basking Ridge, New Jersey.
Aktiekurs
$0.0101
Senast synkroniserad: 2023-12-26
Marknadsvärde
$5.32K
Förändring (1 dag)
741.67%
Förändring (1 år)
0.00%
Land
US
Handel Timber Pharmaceuticals, Inc. (TMBR)

Kategori

Healthcare
Pris TMBR med marknadsvärde på B
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
TMBR
$0.0101
Marknadsvärde för Timber Pharmaceuticals, Inc.(TMBR)
Marknadsvärde: $5.32K
Från och med August 2026 har Timber Pharmaceuticals, Inc. ett börsvärde på $5.32K. Detta gör Timber Pharmaceuticals, Inc. till det 42059th mest värdefulla företaget i världen enligt våra data. Börsvärdet, även kallat market cap, är det totala marknadsvärdet av ett börsnoterat företags utestående aktier och används ofta för att uppskatta ett företags värde.
Marknadsvärdehistorik för Timber Pharmaceuticals, Inc. från 2014 till 2026
TMBR jämfört med topp 5 mest populära stocks
Pris för TMBR Tillgång B Marknadsvärdet för B Resultat
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$10,227,038 $5.32K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +101,257,803,053.34%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$8,403,338 $5.32K
Apple Inc. Apple Inc.
AAPL
$4.423T +83,201,368,693.29%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$7,903,663 $5.32K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +78,254,084,322.11%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$6,959,394 $5.32K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +68,904,895,245.87%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$5,492,612 $5.32K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +54,382,301,214.11%